Natural course of subjects with elevated liver tests and normal liver histology

被引:5
作者
Strasser, Michael [1 ]
Stadlmayr, Andreas [2 ]
Haufe, Heike [3 ]
Stickel, Felix [4 ,5 ]
Ferenci, Peter [6 ]
Patsch, Wolfgang [7 ]
Feldman, Alexandra [1 ,8 ]
Weghuber, Daniel [8 ,9 ]
Datz, Christian [2 ,8 ]
Aigner, Elmar [1 ,8 ]
机构
[1] Paracelsus Med Univ, Dept Med 1, A-5020 Salzburg, Austria
[2] Oberndorf Hosp, Dept Internal Med, Oberndorf, Austria
[3] Paracelsus Med Univ, Dept Pathol, A-5020 Salzburg, Austria
[4] Clin Beau Site, Hepatol Unit, Bern, Switzerland
[5] Univ Zurich Hosp, Dept Gastroenterol & Hepatol, CH-8091 Zurich, Switzerland
[6] Med Univ Vienna, Dept Med Gastroenterol & Hepatol 3, Vienna, Austria
[7] Paracelsus Med Univ, Dept Pharmacol & Toxicol, A-5020 Salzburg, Austria
[8] Paracelsus Med Univ, Obes Res Unit, A-5020 Salzburg, Austria
[9] Paracelsus Med Univ, Dept Pediat, A-5020 Salzburg, Austria
关键词
autoimmune hepatitis; liver; liver biopsy; NAFLD; normal histology; GENOME-WIDE ASSOCIATION; DISEASE; AUTOANTIBODIES; PREVALENCE; HEPATITIS; ENZYMES; BIOPSY; PLASMA;
D O I
10.1111/liv.12935
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Background & Aims: Liver biopsy (LB) is performed if non-invasive work-up of liver disease is inconclusive. The examination of liver tissue occasionally reveals normal histology. Long-term follow-up of such patients has not been performed. Methods: We identified a total 70 subjects from our LB database with elevated liver tests and normal liver histology after a mean of 90.5 +/- 52.3 (range 15-216) months and conducted reassessment of medical history, physical examination, laboratory testing, ultrasound, transient elastography and LB if indicated. Results: At follow-up examination, 15 (7 females (f)/8 males (m); 21.4%) subjects had normal liver tests and no further evidence of liver disease. A subset of 37 (29 f/8 m; 52.9%) subjects had persistently elevated liver tests without evidence indicating progressive liver disease but the cause thereof remained unexplained also at the follow-up visit. Three (0 f/3 m; 4.3%) subjects had consumed excessive alcohol with indicators of alcoholic liver disease. Eleven subjects (4 f/7 m; 15.7%) had developed steatosis on ultrasound examination along with weight gain and/or biochemical features of the metabolic syndrome. In addition, three (2 f/1 m) patients developed autoimmune hepatitis, one female presented with primary biliary cirrhosis. One male was diagnosed with cholangiocellular carcinoma 3 months after the initial evaluation. Conclusion: The clinical course of most patients was benign, but in approximately 20% of the subjects a liver disease developed. Particular attention should be given to autoimmune liver diseases in subjects with positive autoantibodies. In addition, lifestyle factors such as weight gain and alcohol consumption were associated with the manifestation of liver diseases.
引用
收藏
页码:119 / 125
页数:7
相关论文
共 12 条
  • [1] The prevalence of autoantibodies and autoimmune hepatitis in patients with nonalcoholic fatty liver disease
    Adams, LA
    Lindor, KD
    Angulo, P
    [J]. AMERICAN JOURNAL OF GASTROENTEROLOGY, 2004, 99 (07) : 1316 - 1320
  • [2] Utilization of FibroScan in clinical practice
    Bonder A.
    Afdhal N.
    [J]. Current Gastroenterology Reports, 2014, 16 (2)
  • [3] Current concepts: Liver biopsy.
    Bravo, AA
    Sheth, SG
    Chopra, S
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2001, 344 (07) : 495 - 500
  • [4] The Diagnosis and Management of Non-alcoholic Fatty Liver Disease: Practice Guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association
    Chalasani, Naga
    Younossi, Zobair
    Lavine, Joel E.
    Diehl, Anna Mae
    Brunt, Elizabeth M.
    Cusi, Kenneth
    Charlton, Michael
    Sanyal, Arun J.
    [J]. AMERICAN JOURNAL OF GASTROENTEROLOGY, 2012, 107 (06) : 811 - 826
  • [5] Genome-wide association study identifies loci influencing concentrations of liver enzymes in plasma
    Chambers, John C.
    Zhang, Weihua
    Sehmi, Joban
    Li, Xinzhong
    Wass, Mark N.
    Van der Harst, Pim
    Holm, Hilma
    Sanna, Serena
    Kavousi, Maryam
    Baumeister, Sebastian E.
    Coin, Lachlan J.
    Deng, Guohong
    Gieger, Christian
    Heard-Costa, Nancy L.
    Hottenga, Jouke-Jan
    Kuehnel, Brigitte
    Kumar, Vinod
    Lagou, Vasiliki
    Liang, Liming
    Luan, Jian'an
    Vidal, Pedro Marques
    Leach, Irene Mateo
    O'Reilly, Paul F.
    Peden, John F.
    Rahmioglu, Nilufer
    Soininen, Pasi
    Speliotes, Elizabeth K.
    Yuan, Xin
    Thorleifsson, Gudmar
    Alizadeh, Behrooz Z.
    Atwood, Larry D.
    Borecki, Ingrid B.
    Brown, Morris J.
    Charoen, Pimphen
    Cucca, Francesco
    Das, Debashish
    de Geus, Eco J. C.
    Dixon, Anna L.
    Doering, Angela
    Ehret, Georg
    Eyjolfsson, Gudmundur I.
    Farrall, Martin
    Forouhi, Nita G.
    Friedrich, Nele
    Goessling, Wolfram
    Gudbjartsson, Daniel F.
    Harris, Tamara B.
    Hartikainen, Anna-Liisa
    Heath, Simon
    Hirschfield, Gideon M.
    [J]. NATURE GENETICS, 2011, 43 (11) : 1131 - 1138
  • [6] Prospective evaluation of unexplained chronic liver transaminase abnormalities in asymptomatic and symptomatic patients
    Daniel, S
    Ben-Menachem, T
    Vasudevan, G
    Ma, CK
    Blumenkehl, M
    [J]. AMERICAN JOURNAL OF GASTROENTEROLOGY, 1999, 94 (10) : 3010 - 3014
  • [7] Non-organ-specific autoantibodies in nonalcoholic fatty liver disease: Prevalence and correlates
    Loria, P
    Lonardo, A
    Leonardi, F
    Fontana, C
    Carulli, L
    Verrone, AM
    Borsatti, A
    Bertolotti, M
    Cassani, F
    Bagni, A
    Muratori, P
    Ganazzi, D
    Bianchi, FB
    Carulli, N
    [J]. DIGESTIVE DISEASES AND SCIENCES, 2003, 48 (11) : 2173 - 2181
  • [8] Mathiesen UL, 1999, SCAND J GASTROENTERO, V34, P85
  • [9] Exceeding the limits of liver histology markers
    Melita, Shruti H.
    Lau, Bryan
    Afdhal, Nezam H.
    Thomas, David L.
    [J]. JOURNAL OF HEPATOLOGY, 2009, 50 (01) : 36 - 41
  • [10] Findings on liver biopsy to investigate abnormal liver function tests in the absence of diagnostic serology
    Skelly, MM
    James, PD
    Ryder, SD
    [J]. JOURNAL OF HEPATOLOGY, 2001, 35 (02) : 195 - 199